Case Studies for Reimbursement Codes

1. Your company makes wrench A.
2. Clever engineers design wrench B.
3. Clinical is charged with doing a study to show B is better than A.
4. Marketing plans big campaign to sell B at twice the cost of A.

BUT, BUT, BUT, hospital won't pay more for B because Medicare will only reimburse for A. Any increase in price comes out of hospital's profit margin.

Take this e-conference! Learn how to overcome problems and make your company rich!

Is A Reimbursement Code Necessary?
While it is true that your products will not be adequately reimbursed by third party payers without a billing code(s), “getting a code” may not always be a primary goal in obtaining maximum reimbursement for your product. The “How to” steps will be outlined using real-world case studies.

We will cover:
> The decision-making process
> A decision tree for when to go for a new code or not. If going for a new code, specifying the general requirements and timeline.
> If not going for a new code, steps to changing reimbursement for an existing code.
> Strategies for working with CMS and specialty societies.

A brief overview of the reimbursement process will be presented, but a basic understanding of coverage, coding, and reimbursement was previously presented in an event on 23Apr08.

You will receive:
[x] PowerPoint Slides.
[x] Examples and case studies.
[x] Decision tree for when to pursue a new code.
[x] An expert speaker.
[x] A chance for Q&A.
[x] CEUs & Certificate.

Audience Suitability:
[x] All clever engineers.
[x] Clinical research professionals.
[x] Marketing professionals.
[x] Regulatory professionals.
[x] Managers and decision-makers.
[x] Executives for start-up companies.
[x] Investigators for medical device trials.

Presenter:
Mary Ann Clark is Vice President of Health Economics & Reimbursement with Burgess Group. Prior to joining the Burgess Group, Ms. Clark was a Director of Health Economics & Reimbursement at Boston Scientific Neuromodulation (Advanced Bionics) for 8 years, where she developed strategies for overcoming reimbursement and economic barriers to market adoption of cardiovascular, neurovascular, peripheral vascular, women’s health, and neuromodulation products. Early in her career, Ms. Clark was a member of the Harvard research team that developed the RBRVS payment system for the Health Care Financing Administration (Center for Medicare and Medicaid Services) that is now used as the basis for reimbursing physicians under the Medicare program. She has over 15 years experience in the field of health economics and reimbursement and has authored over forty publications on the economic impact of medical technologies. You can reach her at maryann.clark@burgessgroup.com.

The purchase is $422 for OnDemand access and $472 for the CD. Event materials are available by download for OnDemand or are on the CD itself. Each attendee is eligible for 0.15 CEUs upon completing the course feedback via the link provided with the event materials. Click here to purchase.